PTGX - Protagonist Therapeutics, Inc
94.83
3.530 3.722%
Share volume: 745,540
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$91.30
3.53
0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-07-2024 | 08-06-2024 | 11-07-2024 | 02-21-2025 | 05-06-2025 | 08-06-2025 | 11-06-2025 | 02-25-2026 | |
| Assets | |||||||||
| Total Assets | 629.276 M | 614.629 M | 603.857 M | 744.725 M | 742.132 M | 718.006 M | 701.688 M | 668.188 M | |
| Current Assets | 627.553 M | 570.925 M | 476.769 M | 591.641 M | 605.860 M | 602.526 M | 586.424 M | 577.574 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 300.043 M | 43.000 K | 0.000 | 165.000 M | 22.825 M | 23.363 M | 0.000 | 0.000 | |
| Short Term Investments | 150.067 M | 208.354 M | 337.600 M | 321.664 M | 434.707 M | 401.922 M | 462.404 M | 438.974 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 172.568 M | 355.643 M | 131.121 M | 97.249 M | 139.653 M | 168.543 M | 113.713 M | 128.390 M | |
| Total Non-current Assets | 0.000 | 31.447 M | 114.560 M | 140.252 M | 123.517 M | 102.493 M | 102.703 M | 78.638 M | |
| Property Plant Equipment | 1.111 M | 1.780 M | 2.468 M | 3.190 M | 3.530 M | 4.108 M | 4.100 M | 3.860 M | |
| Other Assets | 612.000 K | 41.924 M | 124.620 M | 149.894 M | 132.742 M | 111.372 M | 111.164 M | 86.754 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 629.276 M | 614.629 M | 603.857 M | 744.725 M | 742.132 M | 718.006 M | 701.688 M | 668.188 M | |
| Total liabilities | 68.832 M | 73.305 M | 71.942 M | 69.430 M | 53.080 M | 49.988 M | 56.251 M | 53.481 M | |
| Total current liabilities | 39.910 M | 41.578 M | 44.578 M | 47.398 M | 35.112 M | 35.507 M | 44.942 M | 45.441 M | |
| Accounts Payable | 19.994 M | 18.804 M | 23.788 M | 25.308 M | 14.760 M | 18.646 M | 28.514 M | 33.608 M | |
| Other liabilities | 0.000 | 10.971 M | 10.855 M | 10.356 M | 9.792 M | 9.106 M | 8.521 M | 8.040 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 10.971 M | 10.855 M | 10.356 M | 9.792 M | 9.106 M | 8.521 M | 8.040 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 560.444 M | 541.324 M | 531.915 M | 675.295 M | 689.052 M | 668.018 M | 645.437 M | 614.707 M | |
| Common stock | 969.043 M | 980.559 M | 1.003 B | 1.016 B | 1.041 B | 1.055 B | 1.071 B | 1.085 B | |
| Retained earnings | -408.370 M | -438.986 M | -472.196 M | -340.522 M | -352.177 M | -386.948 M | -426.287 M | -470.671 M |